SVB Securities analyst Andrew Berens downgraded Seagen to Market Perform from Outperform with a $141 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on SGEN:
- Truist sees potential pressure on Seagen’s Padcev in Q4
- Seagen price target lowered to $170 from $183 at Berenberg
- Biotech Alert: Searches spiking for these stocks today
- Seagen label for Tukysa in CRC broader-than-expected, says William Blair
- Seagen announces FDA accelerated approval of TUKYSA-trastuzumab combo